Innovative SRPFM technique enables ultra-sensitive force measurement at nanoscale in fluids

Ten com­pa­nies are now com­pet­ing for mar­ket share with Ab­b­Vie’s megablock­buster rheuma­toid arthri­tis drug Hu­mi­ra (adal­i­mum­ab), but two of those com­peti­tors — Pfiz­er and Boehringer

Mer­ck is stop­ping a Phase 3 tri­al of its pul­monary ar­te­r­i­al hy­per­ten­sion treat­ment Win­re­vair al­most a year ear­ly fol­low­ing pos­i­tive in­ter­im da­ta, the com­pa­ny …